Biocon to invest Rs.75 crore in MAB facility at BangaloreIllustrative image – not actual.

Biocon India has plans to invest Rs.75 crore in its anti-cancer venture at Bangalore. The project would be based on monoclonal anti-bodies (MAB).

← All latest storiesBack to top →